What they were paid
DiaMedica Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $53,000 | $0 | $88,574 | $0 | $141,574 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: DiaMedica Therapeutics Inc. DEF 14A filed April 1, 2026, accession 0001437749-26-010879, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025DiaMedica Therapeutics pays directors a $40,000 cash retainer.
Committees
FY2025 · as the proxy prints themCompensation · Nominating/Governance · Scientific and Clinical Research Committee
The rest of the DiaMedica Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Charles Semba, M.D | Independent Director | $145,972 |
| Daniel O’Connor | Independent Director | $358,273 |
| James Parsons | Chair of the Board | $199,898 |
| Michael Giuffre, M.D | Independent Director | $148,418 |
| Richard Kuntz, M.D | Independent Director | $143,261 |
| Rick Pauls | Director | $0 |
The full DiaMedica Therapeutics compensation record
free company briefThis page is one director within DiaMedica Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat